No Detail Found!

Efficacy of paroxetine with l-methyl folate and without l-methyl folate in the treatment of major depressive disorder

Author(s)
Ali Gul Tunio Department of Pharmacology, Bibi Asifa Dental College,
Daulat Ram Chandka Medical College, Shaheed Mohtarma Benazir Bhutto Medical University Larkana, Pakistan
Ghulam Serwar Shaikh Chandka Medical College, Shaheed Mohtarma Benazir Bhutto Medical University Larkana, Pakistan
Yasmin Shaikh PUMHSW Nawabshah
Abdul Hameed Lanjwani Chandka Medical College, Shaheed Mohtarma Benazir Bhutto Medical University Larkana, Pakistan
Faiza Shaikh Karachi Institute of Medical Sciences, Karachi, Pakistan
Abstract
Objective: To compare the efficacy of Paroxetine with and without L-Methyl folate in patients with major depressive disorder. Methodology: A total of 160 major depressive disorder patients were divided into two groups with 80 patients in each group. All were treated with Paroxetine 20mg/day with L. methyl folate and without L. methyl folate for 2 months. All were examined clinically, and their demographic and medical history was recorded. Data were analyzed by SPSS 22. Results: The symptom “sleep disturbance and weight gain improved significantly in treatment groups (p<0.05) at 90 days. Weight gain reduction was higher (37.5%) for antidepressant Group A: (Paroxetine 20 mg/day). L-methyl folate with Paroxetine were more effective to reduce the depression symptoms than single Paroxetine group and led to substantial symptomatic improvement faster than monotherapy. Conclusion: L-methyl folate with Paroxetine was most effective in reducing the depression symptoms than other Paroxetine alone and led to substantial symptomatic improvement faster than monotherapy.
Publication Details
Page(s) 42-45
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Paroxetine, depressive disorder., L. methyl folate
References
Huang X,Fan Y,Han X,Huang Z,Yu M,Zhang Y .2018 .Association between serum vitamin levels and depression in US adults 20 years or older based on National Health and Nutrition Examination Survey 2005-2006. Int J Environ Res Public Health, 15 : 1215.
Holland K .2022 .Depression and Anxiety: How to Cope with Both. Differences, And More, : .
Ahmed B,Enam SF,Iqbal Z,Murtaza G,Bashir S.,Depression S. .2016 .and anxiety: a snapshot of the situation in Pakistan. Int J Neuro Behav Sci, 4 : 32-6.
Verduijn J,Milaneschi Y,Schoevers RA,Van Hemert AM,Beekman AT,Penninx BW .2015 .Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression. Transl Psych, 5 : e649.
Yeh YW,Ho PS,Kuo SC,Chen CY,Liang CS,Yen CH .2015 .-ADAM. Int J Neuropsychopharmacol, 18 : 20.
Švob Štrac D,Pivac N,Mück-Šeler D.,Function Cognitive .2016 .The Serotonergic System. Transl Neurosci, 7 : 35-49.
Zhang D,Cheng Y,Wu K,Ma Q,Jiang J,Yan Z. .2019 .Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis. BMC Urol, 19 : 1-2.
Trippe BS,Barrentine LW,Curole MV,Tipa E.,Nutritional E. .2016 .Management of Patients with Diabetic Peripheral Neuropathy With L-MethylfolateMethylcobalamin-Pyridoxal-5-Phosphate: Results of A Real-World Patient Experience Trial. Curr Med Res Opin, 32 : 219-27.
Khosravi M,Sotoudeh G,Amini M,Raisi F,Mansoori A,Hosseinzadeh M. .2020 .The relationship between dietary patterns and depression mediated by serum levels of Folate and vitamin B12. BMC Psychiatry, 20 : 1-8.
Tural U,Corapcıoglu A,Bosgelme S,Koroglu G,Unver H,Duman C .2019 .Double Blind Controlled Study of Adding Folic Acid to Fluoxetine in The Treatment of OCD. Psychiatria Danubina, 31 : 69-77.
Nishuty NL,Khandoker MM,Karmoker JR,Ferdous S,Shahriar M,Qusar MS .2019 .Evaluation of serum interleukin-6 and C-reactive protein levels in drug-naïve major depressive disorder patients. Cureus, 11(1) : e3868.
Altaf R,Gonzalez I,Rubino K,Nemec EC,Meta-Analysis EC .2021 .Folate as Adjunct Therapy to SSRI/SNRI for Major Depressive Disorder: Systematic Review. Complement Ther Med, 61 : 102770.
Jain R,Manning S,Cutler AJ,Best, AJ .2020 .Clinical Scenarios for the Use of L-Methylfolate in Patients with MDD. Cns Spectrums, 25 : 750-64.
Blier P,Ward HE,Tremblay P,Laberge L,Hébert C,Bergeron R .2010 .Combination of Antidepressant Medications from Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study. Am J Psych, 167 : 281-8.
Kakar MS,Jehangir S,Mustafa M,Khattak H. Therapeutic M .2017 .Efficacy of Combination Therapy Of L-Methylfolate and Escitalopram in Depression. Pak Armed Forces Med J, 67 : 976-81.
Hoepner CT,McIntyre RS,Papakostas GI .2021 .Impact of supplementation and nutritional interventions on pathogenic processes of mood disorders: A review of the evidence. Nutrients, 13 : 767-9.
Nierenberg AA,Montana R,Kinrys G,Deckersbach T,Dufour S,Baek JH. .2017 .L-Methylfolate for Bipolar I Depressive Episodes: An Open Trial Proof-Of-Concept Registry. J Affect Disord, 207 : 429-33.
Al Maruf A,Poweleit EA,Brown LC,Strawn JR .2022 .Systematic review and meta-analysis of LMethylfolate augmentation in depressive disorders. Pharmacopsychiatry, 55 : 139-47.
Kutzer T,Dick M,Scudamore T,Wiener M,Schwartz T. .2020 .Antidepressant efficacy and side effect burden: an updated guide for clinicians. Drugs Context, : 9.
Dartois LL,Stutzman DL,Morrow M. .2019 .L-Methylfolate Augmentation to Antidepressants for Adolescents with Treatment-Resistant Depression: A Case Series. J Child Adolesc Psychopharmacol, 29 : 386-91.
Halaris A,Sohl E,Whitham EA .2021 .Treatment-resistant depression revisited: a glimmer of hope. J Pers Med, 11 : 155.
0

Citations

0

Downloads

77

Views